Tiago Rodrigues obtained a PharmD at the Faculty of Pharmacy, University of Lisbon (2006) and a PhD in Medicinal Chemistry from the University of Lisbon (2010). After a postdoctoral stay at the ETH Zurich (2011-2015), where he was also a Lecturer (2012-2015), he returned to Portugal as a senior scientist at the Instituto de Medicina Molecular. He was an Invited Assistant Professor at the Faculty of Pharmacy, University of Lisbon (2015-2020) and a Group Leader since 2020. In 2019 he co-founded TargTex, a VC-backed biotech company that develops life-changing therapies for glioblastoma multiforme. He has supervised or co-supervised >25 BSc, MSc and PhD students and postdocs from multiple cultural and scientific backgrounds, and currently supervises a PhD student. He has published 60 peer-reviewed papers in top tier journals (eg. Nature Chemistry, Nature Reviews Chemistry, JACS, PNAS, Angew Chem Int Ed, Chem Sci, ACS Cent Sci, among others), has an h-index of 25, filed 2 patents, contributed 3 book chapters, guest edited for Bioorganic & Medicinal Chemistry and delivered >70 talks. His work has been widely recognized through multiple national and international awards, highlighted in both scientific outlets and social media (e.g. national TV). His research interests lie at the interface of medicinal chemistry, chemical biology, cheminformatics, targeted therapeutics and machine learning/artificial intelligence.